Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements
Search Results:
1-15 of 55554 results
Tiziana launches phase IIa trial of milciclib in HCC patients
Tiziana Life Sciences has started enrolling of patients in its phase IIa clinical trial with cyclin-dependent kinases (CDKs) inhibitor milciclib in patients with refractory hepatocellular carcinoma (HCC).
Contract Research & Services > Clinical Trials > News
Vertex reports positive data from cystic fibrosis trials
Vertex Pharmaceuticals has reported positive data from Phase 1 and Phase 2 trials of three different triple combination regimens in cystic fibrosis (CF) patients who have one F508del mutation and one minimal function mutation (F508del/Min).
Contract Research & Services > Clinical Trials > News
Horizon to acquire GE's gene tech business Dharmacon
By PBR Staff Writer
Gene editing company Horizon Discovery Group (HDG) has agreed to acquire General Electric’s (GE) gene tech business Dharmacon for $85m.
Production & Manufacturing > Manufacturing > News
Emergent BioSolutions to buy GSK’s anthrax treatment raxibacumab
By PKBR Staff Writer
Emergent BioSolutions has agreed to acquire GlaxoSmithKline’s (GSK) anthrax monoclonal antibody, raxibacumab, for around $96m.
Production & Manufacturing > Manufacturing > News
Cellular Technology Limited: A multicolor Natural Killer cell-mediated cytotoxicity detection
| By CTL Laboratories
A multicolor Natural Killer cell-mediated cytotoxicity detection using fluorescence and direct cell imaging.
Contract Research & Services > Clinical Trials > White Papers
GlobalData says acute myeloid leukemia market will cross $1.5bn by 2026
The acute myeloid leukemia (AML) market in the seven major countries (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will grow more than three times from $406m in 2016 to more than $1.5bn by 2026, reflecting a compound annual growth rate of 14%, as per research and consulting firm GlobalData.
Drug Research > Drug Delivery > News
Prana partners with Takeda in Parkinson’s gastrointestinal neuropathology
Prana Biotechnology has entered into a research collaboration with Takeda Pharmaceuticals International to study the potential of its investigational movement disorders compound, PBT434, to slow or prevent neurodegeneration of the gastrointestinal system.
Contract Research & Services > Contract Research > News
Sarepta, BioMarin settle patent litigation over DMD exon-skipping drugs
By PBR Staff Writer
Sarepta Therapeutics and BioMarin Pharmaceutical have settled a global patent litigation relating to the use of the former’s Exondys 51 and all future exon-skipping products for the treatment of Duchenne muscular dystrophy (DMD).
Drug Research > Drug Delivery > News
FDA approves Gilead’s Vosevi to re-treat HCV infection in adults
By PBR Staff Writer
Gilead Sciences has secured approval from the US Food and Drug Administration (FDA) for its Vosevi to re-treat adults with chronic hepatitis C virus (HCV) infection.
Regulatory Affairs > News
CHMP issues positive opinion for Daiichi Sankyo's LIXIANA label update
The European Committee for Medicinal Products for Human Use (CHMP) has recommended approval of a label update for Daiichi Sankyo Europe's LIXIANA, to provide guidance on its use in patients undergoing transoesophageal echocardiography (TEE)-guided and delayed cardioversion.
Production & Manufacturing > Process & Production > News
Valeant to divest Obagi medical products business
Valeant Pharmaceuticals International has agreed to divest its Obagi Medical Products business for $190m in an all-cash deal to Haitong International Zhonghua Finance Acquisition Fund I, L.P.
FDA rejects Amgen’s BLA for osteoporosis treatment Evenity
By PBR Staff Writer
The US Food and Drug Administration (FDA) has rejected Amgen and UCB’s biologics license application (BLA) for Evenity (romosozumab) to treat postmenopausal women with osteoporosis
Regulatory Affairs > News
Sunovion to sell asthma and allergy products to Covis Pharma
Sunovion Pharmaceuticals has agreed to sell the US market rights to its ciclesonide products Alvesco (ciclesonide) Inhalation Aerosol, Omnaris (ciclesonide) Nasal Spray, and Zetonna (ciclesonide) Nasal Aerosol to Covis Pharma.
Contract Research & Services > Contract Services > News
UK awards more than £120m for global health research
The UK’s Department of Health has announced that 33 research units and groups will get over £120m funding for global health research.
Drug Research > Drug Discovery & Development > News
Mayo Clinic, nference launch startup company for drug development
By PBR Staff Writer
Mayo Clinic and nference have jointly formed a new startup to discover and develop therapies for diseases with unmet medical need using artificial intelligence (AI).
Drug Research > Drug Discovery & Development > News

PBR Supplier Recommendations

Patient Focused Medicines Development (PFMD)
Patients Focused Medicine Development (PFMD) is an open, global and collaborative coalition of patient organisations and advocates, pharma and life sciences industry, HTA bodies, national advisory organisations and regulators. Their aim is to drive meaningful patient engagement by co-creating a standardised and globally adopted framework for patient engagement, so that patients' needs and priorities are at the core of medicines development and lifecycle. PFMD was established in 2015 and currently counts 24 members. Their 'Pledge to Patients' campaign encourages members of the medical community to commit to measurable actions to improve patient engagement.... Drug Research > Drug Delivery > Suppliers
Haselmeier - Self-Injection Devices
Haselmeier is a leading developer and manufacturer of innovative self-injection devices featuring proprietary designs, technology and intellectual property. With over four decades of medical device experience, Haselmeier has built up a world class Design and Development Team – working in compliance with regulatory requirements – for the creation, design and industrialization of our innovative self-injection systems used by pharmaceutical and biotechnology companies worldwide. ... Suppliers
CTL Laboratories - Contract Immune Monitoring and Research
Cellular Technology Limited (CTL), headquartered in Shaker Heights, OH, is a privately held biotechnology company that built its reputation as the global leader in the ELISPOT field over the past two decades by establishing the ELISPOT instrumentation and scientific principles that have helped to define the parameters of ELISPOT research for monitoring of Cell-Mediated Immunity.... Contract Research & Services > Clinical Trials > Suppliers
WeylChem Group of Companies. Better chemistry – achieving more.
WeylChem Group of Companies (WCGC) was established in 2005 as the Fine Chemicals platform of International Chemical Investors Group (ICIG), a privately owned industrial holding company. We are a specialised service provider to the agrochemical, pharmaceutical, polymer and specialty chemicals industries, offering custom-, toll-manufacturing as well as advanced intermediates, reagents and performance products.... Production & Manufacturing > Fine & Speciality Chemicals > Suppliers
SHL Healthcare - Developer and Manufacturer for Equipment Solutions
SHL Healthcare develops and manufactures equipment solutions for home, hospital and long-term care use with a focus on patient comfort and functionality. Our broad range of products include medical slings, rehabilitation beds, pressure mattress systems, lifting equipment, medical soft goods and a variety of related accessories. ... Suppliers
See more

PBR White Paper Recommendations

Cellular Technology Limited: A multicolor Natural Killer cell-mediated cytotoxicity detection By CTL Laboratories
A multicolor Natural Killer cell-mediated cytotoxicity detection using fluorescence and direct cell imaging.... Contract Research & Services > Clinical Trials > White Papers Vetter: A unique blend of expertise By Vetter Pharma International
From clinical development to commercial production.... Drug Research > Drug Delivery > White Papers Vetter Development Service - Supporting your compound’s success By Vetter Pharma International
A unique blend of expertise for clinical manufacturing.... Drug Research > Drug Delivery > White Papers Vetter Commercial Manufacturing - Delivering results across the production chain By Vetter Pharma International
A unique blend of capabilities for aseptic fill and finish.... Drug Research > Drug Delivery > White Papers Vetter Packaging Solutions - Delivering your product's potential By Vetter Pharma International
A unique blend of resources for filling and packaging.... Drug Research > Drug Delivery > White Papers See more
1-15 of 55554 results